Literature DB >> 10504061

Non-random spatial association of melanoma and naevi--a morphometric analysis.

J Smolle1, S Kaddu, H Kerl.   

Abstract

Previous studies have shown that congenital as well as acquired melanocytic naevi indicate an increased risk for developing melanoma in individual patients. Most studies stress the importance of melanocytic naevi as melanoma markers, while in some studies they are considered to be direct melanoma precursors. The latter opinion is favoured by the common co-occurrence of melanoma and naevus within one biopsy. The present study examines the question of whether the co-occurrence of melanoma and naevus is a random event or whether melanomas significantly co-localize with pre-existent naevi, which would suggest a precursor role for these naevi. Seven hundred biopsies of primary melanoma were examined for the presence of congenital or acquired naevi according to standard histological criteria. A naevus was found in 143 of the 700 biopsies (20.4%), of which 90 were acquired (12.9%) and 53 were congenital (7.6%). Within each biopsy the exact location of the melanoma and the naevus was determined using an ocular micrometer at a final magnification of 20 x. From these data the frequency of finding a naevus with increasing distance from the melanoma margin was calculated. The frequency of finding a naevus decreased from 2.6% immediately at the melanoma border to 0.3% at a distance of 4.5 mm and 0% at a distance of 5.0 mm. This decrease was statistically highly significant (P<0.001). Similar results were obtained when congenital and acquired naevi were evaluated separately. These data strongly indicate that melanoma and naevi are non-randomly distributed and that both congenital and acquired naevi may be precursors of melanoma.

Entities:  

Mesh:

Year:  1999        PMID: 10504061     DOI: 10.1097/00008390-199908000-00011

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  7 in total

1.  Mutational status of naevus-associated melanomas.

Authors:  D Shitara; G Tell-Martí; C Badenas; M M S S Enokihara; L Alós; A B Larque; N Michalany; J A Puig-Butille; C Carrera; J Malvehy; S Puig; E Bagatin
Journal:  Br J Dermatol       Date:  2015-06-19       Impact factor: 9.302

2.  Massively parallel sequencing analysis of benign melanocytic naevi.

Authors:  John R Lozada; Felipe C Geyer; Pier Selenica; David Brown; Barbara Alemar; Taha Merghoub; Michael F Berger; Klaus J Busam; Allan C Halpern; Britta Weigelt; Jorge S Reis-Filho; Travis J Hollmann
Journal:  Histopathology       Date:  2019-05-24       Impact factor: 5.087

3.  Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.

Authors:  Liesbeth C W Vredeveld; Patricia A Possik; Marjon A Smit; Katrin Meissl; Chrysiis Michaloglou; Hugo M Horlings; Abderrahim Ajouaou; Pim C Kortman; David Dankort; Martin McMahon; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

4.  Wnt signaling potentiates nevogenesis.

Authors:  Jeff S Pawlikowski; Tony McBryan; John van Tuyn; Mark E Drotar; Rachael N Hewitt; Andrea B Maier; Ayala King; Karen Blyth; Hong Wu; Peter D Adams
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

5.  Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.

Authors:  Priyanka L Patel; Anitha Suram; Neena Mirani; Oliver Bischof; Utz Herbig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-08       Impact factor: 11.205

6.  WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis.

Authors:  Pei-Tzu Yang; Jamie N Anastas; Rachel A Toroni; Michi M Shinohara; Jamie M Goodson; Anja K Bosserhoff; Andy J Chien; Randall T Moon
Journal:  EMBO Mol Med       Date:  2012-11-06       Impact factor: 12.137

7.  Mitotic Stress Is an Integral Part of the Oncogene-Induced Senescence Program that Promotes Multinucleation and Cell Cycle Arrest.

Authors:  Dina Dikovskaya; John J Cole; Susan M Mason; Colin Nixon; Saadia A Karim; Lynn McGarry; William Clark; Rachael N Hewitt; Morgan A Sammons; Jiajun Zhu; Dimitris Athineos; Joshua D G Leach; Francesco Marchesi; John van Tuyn; Stephen W Tait; Claire Brock; Jennifer P Morton; Hong Wu; Shelley L Berger; Karen Blyth; Peter D Adams
Journal:  Cell Rep       Date:  2015-08-20       Impact factor: 9.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.